Home Contact Sitemap
About Us Publications Work In Progress Education and Events Privacy Information for Scientists  

Aboriginal People (10)
Asthma (50)
Cancer (185)
Cardiovascular (444)
Continuity of Care (28)
Decision-Making (53)
Diabetes (146)
Diagnostic Testing (74)
Drugs (394)
Emergency Services (122)
Ethics (10)
Geriatrics (173)
Health Economics (73)
Health Human Resources (54)
Health Policy (135)
Health Technology Assessment (22)
Home Care (20)
Mental Health (86)
Methods (155)
Miscellaneous/Other (20)
Musculoskeletal (78)
Nephrology (37)
Neurology (40)
Outcomes (257)
Pediatrics (130)
Performance Measurement (49)
Population Health (117)
Primary Care (156)
Privacy (6)
Resource Utilization (109)
Respiratory (62)
Screening (59)
Stroke (84)
Surgery (113)
Urology (12)
Vascular (17)
Waiting Lists (44)
Women's Health (136)
 
  View publications
  |

Drugs
A comparison of propensity score methods: a case-study estimating the effectiveness of post-AMI statin use
A population-based analysis of outpatient colonoscopy in adults assisted by an anesthesiologist
A population-based assessment of the drug interaction between levothyroxine and warfarin
A population-based assessment of the potential interaction between serotonin-specific reuptake inhibitors and digoxin
A population-based study of anesthesia consultation before major noncardiac surgery
A population-based study of cholinesterase inhibitor utilization for dementia
A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs
Acute treatment of myocardial infarction in Canada 1999-2002
Adherence to multiple sclerosis disease-modifying therapies in Ontario is low
Adherence with statin therapy in elderly patients with and without acute coronary syndromes
Administrative Data Feedback for Effective Cardiac Treatment (AFFECT), a cluster randomized trial
Adoption of adjuvant chemotherapy for non–small-cell lung cancer: a population-based outcomes study
Adverse cardiovascular events during treatment with glyburide (glibenclamide) or gliclazide in a high-risk population
Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: a population-based cohort study
Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials
Adverse effects of observational studies when examining adverse outcomes of drugs: case-control studies with low prevalence of exposure
Age- and gender-related use of low-dose drug therapy: the need to manufacture low-dose therapy and evaluate the minimum effective dose
Age-sex differences in medicinal self-poisonings: a population-based study of deliberate intent and medical severity
Angiotensin inhibition in renovascular disease: a population-based cohort study
Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study
Antibiotic use in long-term care facilities
Anticoagulation control in the peri-hospitalization period
Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis
Antidepressants, metoprolol and the risk of bradycardia
Antidepressants, warfarin and the risk of hemorrhage
Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in Ontario
Antihypertensive medication prescribing in 27,822 elderly Canadians with diabetes over the past decade
Antihypertensive therapy and incidence of type 2 diabetes in an elderly cohort
Antipsychotic and antidepressant drug use in the elderly and the risk of venous thromboembolism
Antipsychotic drug use and mortality in older adults with dementia
Antipsychotic drugs and hyperglycemia in older patients with diabetes
Antipsychotic drugs and the risk of hyperglycemia in older adults without diabetes: A population-based observational study
Antipsychotic medications and drug-induced movement disorders other than Parkinsonism: a population-based cohort study in older adults
Antipsychotic therapy and short-term serious events in older adults with dementia
Antipsychotic use in older adults with Parkinson's disease
Antipsychotic use in the elderly: shifting trends and increasing costs
Antipsychotics and mortality in parkinsonism
Appropriateness of spironolactone prescribing in heart failure patients: a population-based study
ARBs vs. ACEIs and acute coronary syndrome outcomes in elderly patients: a population-based cohort study (UMPIRE study results)
Are broad-spectrum fluoroquinolones more likely to cause Clostridium difficile-associated disease?
Are rates of gastrointestinal bleeding higher following the introduction of COX-2 inhibitors?
Arthritis and related conditions in Ontario
Aspirin use and outcomes in a community-based cohort of 7,352 patients discharged after first hospitalization for heart failure
Association between ACE inhibitors and acute pancreatitis in the elderly
Association between tamoxifen treatment and diabetes: A population-based study
Association between tamsulosin and serious ophthalmic adverse events in older men following cataract surgery
Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases
At A Glance - April 2005
At A Glance - April 2006
At A Glance - April 2007
At A Glance - April 2008
At A Glance - April 2009
At A Glance - April 2010
At A Glance - April 2011
At A Glance - April 2013
At A Glance - December 2003
At A Glance - December 2004
At A Glance - December 2006
At A Glance - December 2007
At A Glance - December 2008
At A Glance - December 2011
At A Glance - February 2005
At A Glance - February 2008
At A Glance - February 2010
At A Glance - February 2011
At A Glance - February 2012
At A Glance - February 2013
At A Glance - January 2004
At A Glance - January 2005
At A Glance - January 2007
At A Glance - January 2008
At A Glance - January 2011
At A Glance - January 2013
At A Glance - July/August 2008
At A Glance - July/August 2003
At A Glance - July/August 2004
At A Glance - July/August 2005
At A Glance - July/August 2007
At A Glance - July/August 2009
At A Glance - July/August 2010
At A Glance - July/August 2012
At A Glance - June 2004
At A Glance - June 2005
At A Glance - June 2006
At A Glance - June 2008
At A Glance - June/July 2011
At A Glance - March 2005
At A Glance - March 2006
At A Glance - March 2007
At A Glance - March 2008
At A Glance - March 2010
At A Glance - March 2011
At A Glance - March 2012
At A Glance - March 2013
At A Glance - May 2003
At A Glance - May 2004
At A Glance - May 2005
At A Glance - May 2006
At A Glance - May 2007
At A Glance - May 2009
At A Glance - May 2010
At A Glance - May 2011
At A Glance - May 2012
At A Glance - November 2003
At A Glance - November 2004
At A Glance - November 2005
At A Glance - November 2006
At A Glance - November 2007
At A Glance - November 2008
At A Glance - November 2010
At A Glance - November 2011
At A Glance - November 2012
At A Glance - October 2003
At A Glance - October 2004
At A Glance - October 2005
At A Glance - October 2006
At A Glance - October 2007
At A Glance - October 2011
At A Glance - September 2004
At A Glance - September 2005
At A Glance - September 2006
At A Glance - September 2007
At A Glance - September 2009
At A Glance - September 2010
At A Glance - September 2011
At A Glance - September 2012
Atypical antipsychotic drugs and risk of ischaemic stroke: population-based retrospective cohort study
Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review
Atypical antipsychotic use and parkinsonism in dementia: Effects of drug, dose, and sex
Atypical antipsychotics and parkinsonism
Atypical antipsychotics and risk of cerebrovascular accidents
Avoiding drug interactions in hospitalized patients
Beta-blockers and cardiovascular outcomes in dialysis patients: A cohort study in Ontario, Canada
Beta-blockers for elective surgery in elderly patients: population based, retrospective cohort study
Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study
Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada
Burden of potentially avoidable anticoagulant-associated hemorrhagic and thromobembolic events in the elderly
Canadian cardiovascular atlas
Cardiac valvulopathy associated with pergolide use
Cardiovascular outcomes after a change in prescription policy for clopidogrel
Cardiovascular risk with non-steroidal anti-inflammatory drugs: Systematic review of population-based controlled observational studies
Case selection for statins was similar in two Canadian provinces: BC and Ontario
Challenges of prescribing low-dose drug therapy for older people
Challenges to evidence-based prescribing in clinical practice
Changes in prescribing patterns following publication of the ALLHAT trial
Changes in rates of upper gastrointestinal hemorrhage after the introduction of cyclooxygenase-2 inhibitors in British Columbia and Ontario
Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence
Cholinesterase inhibitors and adverse pulmonary events in older people with chronic obstructive pulmonary disease and concomitant dementia: a population-based, cohort study
Ciprofloxacin-induced theophylline toxicity: A population-based study
Class effects of statins in elderly patients with congestive heart failure: a population-based analysis
Clinical and demographic characteristics of patients receiving different oral hypoglycemic agents
Clinical consequences of generic warfarin substitution: an ecological study
Clinical evidence, practice guidelines, and β-blocker utilization before major noncardiac surgery
Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians?
Clustering of opioid prescribing and opioid-related mortality among family physicians in Ontario
CNODES: the Canadian Network for Observational Drug Effect Studies
Comparative adherence to oxybutynin or tolterodine among older patients
Comparing clinical and administrative data for profiling hospitals on postdischarge medication use by patients with acute myocardial infarction
Comparison of angiotensin-converting enzyme inhibitors in the treatment of congestive heart failure
Comparison of inhaled long-acting beta-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: A cohort study
Concordance between discharge prescriptions and insurance claims in post-myocardial infarction patients
Confidential prescriber feedback and education to improve antibiotic use in primary care: a controlled trial
Cost analysis of therapeutic interchange of calcium channel blockers for the treatment of hypertension: unexpected results from a conversion program
Cost-effectiveness of educational outreach to primary care nurses to increase tuberculosis case detection and improve respiratory care: economic evaluation alongside a randomised trial
Current prescription patterns and safety profile of irreversible monoamine oxidase inhibitors: a population-based cohort study of older adults
Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study
Deliberate self-poisoning in Ontario following the terrorist attacks of September 11th, 2001
Delirium after elective surgery among elderly patients taking statins
Dependence and addiction during chronic opioid therapy
Diabetes in Ontario
Diabetes is not treated as a coronary artery disease risk equivalent
Dihydropyridine calcium channel blockers and the progression of parkinsonism
Discontinuity of chronic medications in patients discharged from the intensive care unit
Does statin therapy decrease the risk for bleeding in patients who are receiving warfarin?
Drug policy: making drugs available without bankrupting the healthcare system
Drug problems among homeless individuals in Toronto, Canada: prevalence, drugs of choice, and relation to health status
Drug-drug interactions among elderly patients hospitalized for drug toxicity
Drug-induced lithium toxicity in the elderly: a population-based study
Duration of anticoagulation following venous thromboembolism: a meta-analysis
Economic evaluations in the Canadian Common Drug Review
Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial
Effect of age on stroke prevention therapy in patients with atrial fibrillation
Effect of an explicit decision-support tool on decisions to prescribe antibiotics for sore throat
Effect of cost-sharing on use of asthma medication in children
Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysis
Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infaction in the elderly
Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study
Effectiveness and safety of drug-eluting stents in Ontario
Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect
Effects of cholinesterase inhibitors on postoperative outcomes of older adults with dementia undergoing hip fracture surgery
Effects of use of specialty services on disease-modifying antirheumatic drug use in the treatment of rheumatoid arthritis in an insured elderly population
Efficacy of angiotensin II receptor antagonists in preventing headache: a systematic overview and meta-analysis
Electroconvulsive therapy in older adults: 13-year trends
Epidural anaesthesia and survival after intermediate-to-high risk non-cardiac surgery: a population-based cohort study
Estimating influenza vaccine effectiveness in community-dwelling elderly patients using the instrumental variable analysis method
Estrogen replacement therapy in postmenopausal women: evidence, practice and communication
Exploring variation in rates of polypharmacy across long-term care homes
Facing up to the prescription opioid crisis
Factors associated with initiation and completion of the quadrivalent human papillomavirus vaccine series in an Ontario cohort of Grade 8 girls
Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction
Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study
Fracture types and risk factors in men with prostate cancer on androgen deprivation therapy: a matched cohort study of 19,079 men
From pharmacotherapy to pharmacoprevention: trends in prescribing to older adults in Ontario, Canada, 1997-2006
Gaps in the evaluation and monitoring of new pharmaceuticals: proposal for a different approach
Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study
Guillain-Barré syndrome after influenza vaccination in adults: a population-based study
Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents
Hip fractures in users of first- vs. second-generation bisphosphonates
Hospital funding for new drug technologies
How complete are drug history profiles that are based on public drug benefit claims?
How many "me-too" drugs are enough? The case of physician preferences for specific statins
Hypertension management in the elderly has improved: Ontario prescribing trends, 1994 to 2002
Hypokalemia following polyethylene glycol-based bowel preparation for colonoscopy in older hospitalized patients with significant comorbidities
Impact of a fluoroquinolone restriction policy in an elderly population
Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis
Impact of restrictive prescription plans on heart failure medication use
Impact of the PROVE IT-TIMI 22/REVERSAL trials on trends in intensive vs. moderate statin therapy in Ontario, Canada
Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: a population-based nested case-control study
Improving drug benefits for children with asthma: results of a multi-stakeholder workshop to build a research agenda
Inappropriate prescribing before and after nursing home admission
Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective study
Incidence of delirium in older adults newly prescribed lithium or valproate: a population-based cohort study
Inclusion of drugs in provincial drug benefit programs: who is making these decisions, and are they the right ones?
Incorporating pharmacosurveillance in provincial drug formulary decision-making
Influence of socioeconomic status on drug selection for the elderly in Canada
Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease: A population-based study
Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease
Inhaled glucocorticoids in COPD: immortal time bias
Inhaled or systematic corticosteroids and the risk of hospitalizations for hip fracture among elderly women
Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study
Initial patterns of use of COX-2 inhibitors by elderly patients in Ontario: findings and implications
Initiation of benzodiazepines in the elderly after hospitalization
Iron poisoning in young children: association with the birth of a sibling
Is ramipril really better than other angiotensin-converting enzyme inhibitors after acute myocardial infarction?
Is there an association between lipid-lowering drugs and cholecystectomy?
Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study
Levothyroxine dose and risk of fractures in older adults: Nested case-control study
Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox
Long-term analgesic use following low-risk surgery: a retrospective cohort study
Long-term outcomes of regional variations in intensity of invasive vs. medical management of Medicare patients with AMI
Long-term safety and effectiveness of drug-eluting stents for the treatment of saphenous vein grafts disease: A population-based study
Long-term trends in use of and expenditures for cardiovascular medications in Canada
Macrolide-induced digoxin toxicity: a population-based study
Major trauma in elderly adults receiving lipid-lowering medications
Management of neuropsychiatric symptoms in long-term care residents with Parkinson's Disease: a retrospective cohort study
Mental health-related drug utilization among older adults: prevalence, trends, and costs
Missed opportunities in the secondary prevention of myocardial infarction: an assessment of the effects of statin underprescribing on mortality
Mortality among patients with hypertension from 1995 to 2005: a population-based study
Neuroleptic drug therapy in older adults newly admitted to nursing homes: incidence, dose and specialist contact
New fibrate use and acute renal outcomes in elderly adults
New thyroxine treatment in older adults beginning lithium therapy: implications for clinical practice
New use of rosiglitazone decreased following publication of a meta-analysis suggesting harm
Nursing time devoted to medication administration in long-term care: clinical, safety, and resource implications
Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs
Older men with dementia at greater risk than women of serious events after initiating antipsychotic therapy
Opioid dose and drug-related mortality in patients with nonmalignant pain
Opioid dose and risk of road trauma in Canada
Opioids and dose-related deaths — association or causation? — Reply
Optimizing prescribing for older women: a program to evaluate the benefits of low dose cardiovascular medications
Oral bisphosphonate use in the elderly is not associated with acute kidney injury
Oral contraceptives: a risk factor for squamous cell carcinoma?
Osteoporosis medication prescribing in British Columbia and Ontario: Impact of public drug coverage
Osteoporosis prescribing trends in primary care: a population-based retrospective cohort study
Outpatient gatifloxacin therapy and dysglycemia in older adults
Patients treated with aspirin after a first myocardial infarction who also receive a proton pump inhibitor have a higher incidence of cardiovascular events — Letter
Patterns of use of thienopyridine therapy after percutaneous coronary interventions with drug-eluting stents and bare-metal stents
Perioperative beta-blocker therapy in vascular surgery: clinical update
Persistence with bisphosphonate therapy in older people
Persistence with therapy among patients treated with warfarin for atrial fibrillation
Pill Drill
Polymorphism of the MDR1/ABCB1 C3435T drug-transporter and resistance to anticonvulsant drugs: a meta-analysis
Polytherapy with two or more antihypertensive drugs to lower blood pressure in elderly Ontarians: room for improvement
Population rates of hospitalization for atrial fibrillation/flutter in Canada
Postmenopausal estrogen replacement therapy and increased rates of cholecystectomy and appendectomy
Postoperative pneumonia in elderly patients receiving acid suppressants: a retrospective cohort analysis
Postpartum maternal codeine therapy and the risk of adverse neonatal outcomes: a retrospective cohort study
Potential savings of harmonising hospital and community formularies for chronic disease medications initiated in hospital
Potentially inappropriate prescribing in Canada relative to the US
Potentially inappropriate prescribing in Ontario community-dwelling older adults and nursing home residents
Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated
Potentially unintended discontinuation of long-term medication use after elective surgical procedures
Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study
Preoperative statin use and postoperative acute kidney injury
Prescribing for seniors: neither too much nor too little
Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone
Prescribing patterns for Alzheimer disease: survey of Canadian family physicians
Prescriptions for estrogen replacement therapy in Ontario before and after publication of the Women's Health Initiative study
Prevalence of antidepressant use among older people: population-based observations
Prevalence, predictors and outcomes of primary nonadherence after acute myocardial infarction
Primary care in Ontario
Primary prevention drug therapy: can it meet patients' requirements for reduced risk?
Prognostic implications of warfarin cessation after major trauma: a population-based cohort analysis
Progressive trends in the prevalence of benzodiazepine prescribing in older people in Ontario, Canada
Proton pump inhibitors and hospitalization for Clostridium Difficile-associated disease: a population-based study
Proton pump inhibitors: compliance with a mandated step-up program
Published randomized controlled trials of drug therapy for dementia often lack complete data on harm
Quality of cardiac care in Ontario: EFFECT (enhanced feedback for effective cardiac treatment)
Quality of cardiac care in Ontario: EFFECT Study Phase I Report 2
Quality of pharmaceutical industry press releases based on original research
Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderly
Rapid expansion of intravitreal drug injection procedures, 2000 to 2008
Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction
Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study
Recommendations for establishing a citizens' council to guide drug policy in Ontario
Reformulation of controlled-release oxycodone and pharmacy dispensing patterns near the US–Canada border
Reinitiation of anticoagulation after warfarin-associated intracranial hemorrhage and mortality risk: The Best practice for Reinitiating Anticoagulation therapy after INtracranial bleeding (BRAIN) study
Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction
Reporting of gender-related information in clinical trials of drug therapy for myocardial infarction
Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement
Representation of patients with dementia in clinical trials of donepezil
Rescue percutaneous coronary interventions for failed fibrinolytic therapy in ST-segment elevation myocardial infarction: A population-based study
Risk modification for diabetic patients. Are other risk factors treated as diligently as glycemia?
Risk of serious falls associated with oxybutynin and tolterodine: A population based study
Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors
Risk-treatment mismatch in the pharmacotherapy of heart failure
Routine utilization of glycoprotein IIb/IIIa inhibitor therapy is associated with improved in-hospital outcome after percutaneous coronary intervention: insights from a large prospective single-centre registry
Safety and effectiveness of drug-eluting and bare-metal stents for patients with off- and on-label indications
Safety and effectiveness of drug-eluting stents among diabetic patients: a propensity analysis
Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies
Safety of glycoprotein IIb/IIIa inhibitors in urgent or emergency coronary artery bypass graft surgery
Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000
Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study
Selective serotonin reuptake inhibitors and pulmonary arterial hypertension: A case-control study
Socioeconomic status, access to health care, and outcomes after acute myocardial infarction in Canada's universal health care system
Statin use and survival outcomes in elderly patients with heart failure
Statin use and the risk of surgical site infections in elderly patients undergoing elective surgery
Statin use associates with a lower incidence of acute kidney injury after major elective surgery
Statins and intracerebral hemorrhage: a retrospective cohort study
Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis
Survival in Parkinson disease: 13-year follow-up of the DATATOP cohort
Survival with tiotropium compared to long-acting Beta-2-agonists in chronic obstructive pulmonary disease
Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors
Systematic review of strategies to measure HIV-related diarrhea
Temporal trends in medication use and outcomes in atrial fibrillation
The 2003 Canadian recommendations for dyslipidemia management: revisions are needed
The challenges of prescribing drug therapy to older people
The effect of antidepressant warnings on prescribing trends in Ontario, Canada
The effect of computerized physician order entry with clinical decision support on the rates of adverse drug events: a systematic review
The effect of hospitalization on oral anticoagulation control: a population-based study
The effect of universal influenza immunization on antibiotic prescriptions: an ecological study
The impact of federal warnings on publically funded desmopressin utilization among children in Ontario
The impact of rural residence on medically serious medicinal self-poisonings
The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends
The impact of the Women's Health Initiative study on incident clonidine use in Ontario, Canada
The prescription of insulin pen devices versus syringes for older people with diabetes
The relationship between variations in antipsychotic prescribing across nursing homes and short-term mortality: quality of care implications
The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers
The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants
The risk of suicide with selective serotonin reuptake inhibitors in the elderly
The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis
The safety of levofloxacin in elderly patients on warfarin
The striking effect of the 'Heart Outcomes Prevention Evaluation' (HOPE) on ramipril prescribing in Ontario
The timing of drug funding announcements relative to elections: a case study involving dementia medications
Trends in antihypertensive drug prescriptions and physician visits in Canada between 1996 and 2006
Trends in heart failure outcomes and pharmacotherapy: 1992 to 2000
Trends in hormonal management of prostate cancer: a population-based study in Ontario
Trends in opioid use and dosing among socio-economically disadvantaged patients
Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada
Trial prescriptions to reduce drug wastage: results from Canadian programs and a community demonstration project
Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: Nested case-control study
Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the Renin-Angiotensin system: a population-based study
Trimethoprim/sulfamethoxazole-induced phenytoin toxicity in the elderly: A population-based study
Turning 65 in Ontario: the impact of public drug benefit coverage on hospitalizations for acute and chronic disease
Universal drug coverage and socioeconomic disparities in major diabetes outcomes
Uptake and outcomes associated with cyclooxgenase (COX-2) inhibitors in Ontario's elderly
Use of angiotensin-converting enzyme inhibitor therapy and dose-related outcomes in older adults with new heart failure in the community
Use of antidepressants among Canadian workers receiving depression-related short-term disability benefits
Use of antidepressants among elderly subjects: trends and contributing factors
Use of beta-blocker therapy in older patients after acute myocardial infarction in Ontario
Use of beta-blockers for uncomplicated hypertension in the elderly: a cause for concern
Use of calcium channel blockers after stroke is not associated with poor outcome: a cohort from the Registry of the Canadian Stroke Network
Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction
Use of ezetimibe in the United States and Canada
Use of fibrates in the United States and Canada
Use of other opioids during methadone therapy: a population-based study
Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people
Use of statins and the subsequent development of deep vein thrombosis
Use of the statins in patients after acute myocardial infarction: does evidence change practice?
Use of vascular risk-modifying medications for diabetic patients differs between physician specialties
Use of vitamin B12 injections among elderly patients by primary care practitioners in Ontario
Using OHIP physician billing claims to ascertain individual influenza vaccination status
Using pharmacoepidemiology to inform drug coverage policy: initial lessons from a two-province collaborative
Variation in nursing home antipsychotic prescribing rates
Variation in the days supply field for osteoporosis medications in Ontario
Vitamin B12 injections versus oral supplements. How much money could be saved by switching from injections to pills?
Volume 10, No 4 of informed - October 2004 [360 KB PDF]
Volume 13, No 1 of informed - January 2007 [1.5 KB PDF]
Volume 9, No 2 of informed - April 2003 [582 KB PDF]
Volume 9, No 3 of informed - July 2003 [697 KB PDF]
Volume 9, No 4 of informed - October 2003 [703 KB PDF]
Warfarin prescribing in atrial fibrillation: the impact of physician, patient and hospital characteristics
Warfarin therapy and risk of hip fracture among elderly patients
What effects do provincial drug plan coverage policies for new drugs have on patterns of use and cost?
When laboratories report estimated glomerular filtration rates in addition to serum creatinines, nephrology consults increase

About Us Publications Work In Progress Education and Events Privacy Information for Scientists  

Copyright© 1992-2011 Institute for Clinical Evaluative Sciences (ICES)

 Terms of Use
ICES logo - Institute for Clinical Evaluative Sciences (ICES) Home Page ICES Home Page Link Sitemap: Can't find what you are looking for? Click here for a list of webpages available to you.